From €6850EUR$7,500USD£5,858GBP
- Report
- October 2024
- 189 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- March 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- March 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- July 2023
- 110 Pages
Global
From €4110EUR$4,500USD£3,515GBP
- Report
- August 2022
- 245 Pages
North America
From €3151EUR$3,450USD£2,694GBP
- Report
- April 2023
- 80 Pages
Vietnam
From €1370EUR$1,500USD£1,172GBP
- Report
- April 2023
- 80 Pages
United States
From €1370EUR$1,500USD£1,172GBP
- Report
- April 2023
- 80 Pages
United Kingdom
From €1370EUR$1,500USD£1,172GBP
From €1370EUR$1,500USD£1,172GBP
- Report
- April 2023
- 80 Pages
South Korea
From €1370EUR$1,500USD£1,172GBP
- Report
- April 2023
- 80 Pages
Saudi Arabia
From €1370EUR$1,500USD£1,172GBP
- Report
- April 2023
- 80 Pages
Russia
From €1370EUR$1,500USD£1,172GBP
- Report
- April 2023
- 80 Pages
Poland
From €1370EUR$1,500USD£1,172GBP
- Report
- April 2023
- 80 Pages
Japan
From €1370EUR$1,500USD£1,172GBP
- Report
- April 2023
- 80 Pages
Ireland
From €1370EUR$1,500USD£1,172GBP
- Report
- April 2023
- 80 Pages
India
From €1370EUR$1,500USD£1,172GBP
- Report
- April 2023
- 80 Pages
Germany
From €1370EUR$1,500USD£1,172GBP
- Report
- April 2023
- 80 Pages
France
From €1370EUR$1,500USD£1,172GBP
- Report
- April 2023
- 80 Pages
China
From €1370EUR$1,500USD£1,172GBP

Pertussis, also known as whooping cough, is a highly contagious respiratory infection caused by the bacterium Bordetella pertussis. It is a major cause of morbidity and mortality in children, particularly in developing countries. In pulmonary medicine, pertussis is treated with antibiotics, such as macrolides, and supportive care. Vaccination is the most effective way to prevent pertussis, and is recommended for all children and adults.
The pertussis market is a subset of the global pulmonary medicine market, which is estimated to reach $50 billion by 2027. The pertussis market is driven by the increasing prevalence of the disease, the rising demand for vaccines, and the growing awareness of the importance of vaccination.
Some companies in the pertussis market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Johnson & Johnson. Show Less Read more